Mandate

Vinge advises Acrinova AB (publ) in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Acrinova AB (publ) (“Acrinova” or the “Company”) in connection with the Company’s uplisting to Nasdaq Stockholm. The prospectus was published on 9 December 2022 and trading on Nasdaq Stockholm commenced on 16 December 2022.

Acrinova is a real estate group with a focus on southern Sweden and on commercial properties. The Company offers comprehensive services as owner, manager and developer of real estate. Acrinova has its headquarter in Malmö, Sweden. The Company is uplisting from Nasdaq First North Premier Growth Market, where the Company's shares have been listed since 2019.

Vinge’s team has primarily consisted of Linnéa SellströmEmma Brolund, Lorin Arabi and Michaela Ådén (Capital Markets and Public M&A), as well as Victor Ericsson, Emelie Svanberg and Maja Prahl (Corporate Tax).

 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025